Deal<

DEAL OF THE YEAR (<£500M)


This award recognises the teams and organisations who have executed a truly transformational and high value creating deal for both the company and the wider industry. The deal could be a licensing agreement, co-development or a creative alliance or partnership that unlocks significant value.

Qualifying criteria
 
- Deal size must be less than £500m
- The lead company must be a European Life Science company
- Open to private or public companies WITH pharma, commercial leaders or big tech
- Deal can be either a licensing deal involving a particular drug, project or group of drugs/projects
- A license, partnership or alliance between companies NOT M&A
- Deal to have completed in the period between 1 September 2018 and 1 September 2019

Judges will be paying particular attention to:

- Uniqueness or novelty of deal strategy / terms and structure
- Level of value creation / size of deal (upfront, milestone and total value)
- Strength of partner / partnership and deal teams
- Potential game / industry changing implications within next 12-months
- Post-deal performance
 
 
SUBMIT YOUR NOMINATION